Accession Number: | 0000899243-21-001376 |
Date: | 2021-01-05 |
Issuer: | FORMA THERAPEUTICS HOLDINGS, INC. (FMTX) |
Original Submission Date: |
VICKERS SELWYN M MD
C/O FORMA THERAPEUTICS HOLDINGS, INC.,
500 ARSENAL STREET, SUITE 100
WATERTOWN, MA 02472
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 34.29 | 2021-01-05 | deemed execution date | A | 25,000 (a) | 2031-01-04 | common stock 25,000 | $34.29 | 0 | direct |
ID | footnote |
---|---|
f1 | 33.3% of the shares subject to the stock option shall vest on january 5, 2022; and the remainder of the shares shall vest in equal monthly installments for a period of 24 months thereafter, subject to continued service with the issuer. |